N-2-N-7-Diisopropyl-9H-fluorene-2,7-disulfonamide 13 23

N-2-N-7-Ditetrahydropyryl-9H-fluorene-2,7-disulfonamide 14 24
N-isopropyl-9H-fluorene-2-sulfonamide 15 25
N-(p-tolyl)-9H-fluorene-2-sulfonamide 16 26
Pyrrolidyl-9H-fluorene-2-sulfonamide 17 
N-2-(2-Hydroxyethyl)-N-7-(p-tolyl)-9H-fluorene-2,7-disulfonamide 30 35
N-2-(2-Hydroxypropyl)-N-7-(p-tolyl)-9H-fluorene-2,7-disulfonamide 31 36
Sodium 9H-fluorene-2,7-disulfonate (1.62 g, 4.50 mmol), PCl 5 (2.29 g, 13.5 mmol) and POCl 3 (5.00 mL, 54.00 mmol) were heated to reflux for 16 hours. POCl 3 was removed by distillation before water (50 mL) was added slowly and the slurry sonicated to break up the aggregates. The solid obtained was filtered to obtain 9H-fluorene-2,7-disulfonyl dichloride 4 as a brown solid, (0 
General Procedure 2 (chlorination)
9H-Fluorene-2-sulfonyl chloride 6
To a suspension of sodium 9H-fluorene-2-sodium sulfonate (2.50 g, 9.31 mmol) in CH 2 Cl 2 (100 mL) was added oxalyl chloride (2.36 mL, 28 mmol) and a few drops of anhydrous N,N-dimethylformamide (DMF). The mixture was heated to 40 °C for 3 hours then filtered through Celite. The solid was washed with CH 2 Cl 2 (2 × 100 mL) and concentrated in vacuo to afford 6 as a brown solid, (2.32 g, 94%); 
7-Bromo-9H-fluorene-2-sulfonyl chloride 19
General procedure 1 was followed using 2-bromofluorene (2.02 g, 8.24 mmol), acetic acid (10 mL) and chlorosulfonic acid (0.49 mL, 7.43 mmol) to give sodium 7-bromo-9H-fluorene-2-sulfonate as a brown solid that was used directly without characterisation, (2.46 g). General procedure 2 was followed using sodium 7-bromo-9H-fluorene- 
7-Iodo-9H-fluorene-2-sulfonyl chloride 25
General procedure 2 was followed using sodium 7-iodo-9H-fluorene- ClO 2 S 389.8978, found 389.8976.
General Procedure 3 (Sulfonamide formation)
9H-Fluorene-2,7-disulfonyl dichloride (100 mg, 0.28 mmol), acetone (1.52 mL), THF (0.28 mL), amine (0.56 mmol) and 2M NaOH (aq) (0.32 mL) were added to a 5 mL microwave vial equipped with a magnetic stirrer bar. The mixture was heated in a microwave at 100 °C for 15 min, and allowed to cool to room temperature. CH 2 Cl 2 (10 mL) was added, and the mixture washed with water (10 mL), saturated sodium carbonate solution (10 mL), 2M HCl (aq) solution (10 mL) and brine (10 mL). The organic extract was dried over magnesium sulfate, filtered and concentrated under reduced pressure to give the crude product. 
N,N-Bis(4-hydroxyphenyl)-9H-fluorene-2,7-disulfonamide 10
Prepared by General Procedure 3, heating for an additional 50 min using 4-hydroxyaniline (60 mg, 0.55 mmol). Purified by column chromatography on silica (7% MeOH in CH 2 Cl 2 , followed by 10%) to give 10 as a yellow-orange solid (48 mg, 34%); 
N,N-Dicyclohexyl-9H-fluorene-2,7-disulfonamide 12
Prepared by General Procedure 3, using cyclohexylamine (0.063 mL, 0.55 mmol). Purified by column chromatography on silica (1:1 petroleum ether: ethyl acetate, followed by 1:3) to give 12 as a brown solid (81 mg, 60%); m. 
N,N-Bis(tetrahydro-2H-pyran-4-yl)-9H-fluorene-2,7-disulfonamide 14
Prepared by General Procedure 3, using 4-aminotetrahydropyran (0.06 mL, 0.58 mmol). Purified by column chromatography on silica (1:1 petroleum ether: ethyl acetate, followed by 1:2) to give 14 as a light yellow solid, which was further purified by trituration with diethyl ether (5 × 5 mL) (74 mg, 55%); m.p. 242-246 °C (decomp.); IR (ATR/cm 9H-Fluorene-2-sulfonyl chloride (1.51 g, 5.7 mmol), acetone (9.0 mL), THF (2.25 mL), p-toluidine (0.611 g, 5.7 mmol) and 2M NaOH (aq) (2.57 mL) were added to a 20 mL microwave vial equipped with a magnetic stirrer bar. The mixture was heated in a microwave at 100 °C for 15 min, and allowed to cool to room temperature. CH 2 Cl 2 (50 mL) was added, and the mixture washed with water (30 mL), saturated sodium carbonate solution (30 mL), 2M HCl (aq) solution (30 mL) and brine (30 mL). The organic extract was dried over magnesium sulfate, filtered and concentrated under reduced pressure to give the crude product, which was purified by column chromatography on silica As in the synthesis of 16, using 9H-fluorene-2-sulfonyl chloride (1.00 g, 3.8 mmol), acetone (25 mL), THF (4.60 mL), isopropylamine (0.33 mL, 3.8 mmol) and 2M NaOH (aq) (2.13 mL 
1-((9H-Fluoren-2-yl)sulfonyl)pyrrolidine 17
As in the synthesis of 16, using 9H-fluorene-2-sulfonyl chloride (3.48 g, 13.1 mmol), acetone (95.0 mL), THF (18.4 mL), pyrrolidine (1.26 mL, 3.8 mmol) and 2M NaOH (aq) (8.5 mL) split into 8 separate microwave vials. The crude product was purified by column chromatography on silica 
7-Bromo-N-(p-tolyl)-9H-fluorene-2-sulfonamide 20
As in the synthesis of 16, using 7-bromo-9H-fluorene-2-sulfonyl chloride (1.00 g, 2.91 mmol), acetone (16.10 mL), THF (2.94 mL), p-toluidine (0.312 g, 2.91 mmol) and 2M NaOH (aq) (1.34 mL). The crude product was purified by column chromatography 3: 
7-Iodo-N-(p-tolyl)-9H-fluorene-2-sulfonamide 26
7-Iodo-9H-fluorene-2-sulfonyl chloride (0.50 g, 1.28 mmol) and p-toluidine (0.28 g, 2.61 mmol) were added to a mixture of acetone (14.0 mL) and THF (1. 
4-((7-Iodo-9H-fluoren-2-yl)sulfonyl)morpholine 27
As in the synthesis of 26, using 7-iodo-9H-fluorene-2-sulfonyl chloride (1.00 g, 2.56 mmol), morpholine (0.50 mL, 5.78 mmol), acetone (35 mL) and THF (2.4 mL) to give the crude product as a peach coloured solid, which was purified by column chromatography on silica ( 
7-(N-(p-Tolyl)sulfamoyl)-9H-fluorene-2-sulfonic acid 28
9H-Fluorene-2,7-disulfonyl dichloride (0.50 g, 1.38 mmol), acetone (7.50 mL), THF (1.40 mL), p-toluidine (0.148 g, 1.38 mmol) and 2M NaOH (aq) (0.80 mL) were added to a 20 mL microwave vial equipped with a magnetic stirrer bar. The mixture was heated in a microwave at 100 °C for 15 min, and allowed to cool to room temperature. Ethyl acetate (30 mL) was added, and the mixture washed with water (20 mL), saturated sodium carbonate solution (20 mL), 2M HCl (aq) solution (20 mL) and brine (20 mL). The organic extract was dried over magnesium sulfate, filtered and concentrated under reduced pressure to give the crude product, which was purified by column chromatography on silica (3:1 petroleum ether: ethyl acetate, followed by 2.5:1) to give 28 as a yellow solid (87 mg, 15%); m.p. 100 °C (decomp.); IR (ATR/cm 
N-(2-Hydroxyethyl)-N-(p-tolyl)-9H-fluorene-2,7-disulfonamide 30
General Procedure 2 was followed using 28 (0.203 g, 0.49 mmol), oxalyl chloride (0.50 mL, 5.96 mmol), CH 2 Cl 2 (5.0 mL) and DMF (1 drop) to give 29 as a black solid that was used directly without characterisation, (0.150 g). As in the synthesis of 16, using 7-(N-(p-tolyl)sulfamoyl)-9H-fluorene-2-sulfonyl chloride (100 mg, 0.23 mmol), acetone (1.52 mL), THF (0.28 mL), 3-aminopropanol (0.02 mL) and 2M NaOH (aq) (0.13 mL). The crude product was purified by column chromatography (1:1 petroleum ether: ethyl acetate, followed by 1:1.5, 1:3 and ethyl acetate) and then by trituration with n-hexane to give 30 as a white solid (100 mg, 95%); 
N-(3-Hydroxypropyl)-N-(p-tolyl)-9H-fluorene-2,7-disulfonamide 31
As in the synthesis of 16, using 7-(N-(p-tolyl)sulfamoyl)-9H-fluorene-2-sulfonyl chloride (143 mg, 0.33 mmol), acetone (2.10 mL), THF (0.40 mL), 3-aminopropanol (0.02 mL) and 2M NaOH (aq) (0.19 mL). The crude product was purified by column chromatography (1:1 petroleum ether: ethyl acetate, followed by 1:1. 
7-(Morpholine-4-carbonyl)-N-(p-tolyl)-9H-fluorene-2-sulfonamide 23
A mixture of palladium acetate (2.0 mg, 0.05 eq.), Xantphos (6.0 mg, 0.05 eq.), Molybdenum hexacarbonyl (53.0 mg, 0.05 equiv.), DMAP (37.0 mg, 0.30 mmol), 7-bromo-N-(p-tolyl)-9H-fluorene-2-sulfonamide (83.0 mg, 0.20 mmol) and morpholine (0.034 mL, 0.39 mmol) in 1,4-dioxane (0.50 ml) was sealed and heated in a Biotage Initiator at 90 °C for 30 min. After cooling, the reaction mixture was passed through celite using MeOH (10.0 mL), then concentrated under reduced pressure to give the crude product, which was purified by column chromatography (4:1 petroleum ether: ethyl acetate) to give 22 as a yellow solid
